Perrigo Company plc Finance Lease, Right-of-Use Asset, Amortization
Perrigo Company plc (PRGO) reported Finance Lease, Right-of-Use Asset, Amortization of $500.00 thousand for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-05
- Perrigo Company plc finance lease, right-of-use asset, amortization for the quarter ending 2026-06-27 was $500.00K, a 16.67% decline year-over-year.
- Perrigo Company plc finance lease, right-of-use asset, amortization for the quarter ending 2026-03-28 was $500.00K, a 0.00% change year-over-year.
- Perrigo Company plc finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $600.00K, a 0.00% change year-over-year.
- Perrigo Company plc finance lease, right-of-use asset, amortization for the quarter ending 2025-09-27 was $600.00K, a 0.00% change year-over-year.
- Perrigo Company plc finance lease, right-of-use asset, amortization for fiscal 2025 was $2.30M, a 0.00% change from fiscal 2024.
- Perrigo Company plc finance lease, right-of-use asset, amortization for fiscal 2024 was $2.30M, a 63.49% decline from fiscal 2023.
- Perrigo Company plc finance lease, right-of-use asset, amortization for fiscal 2023 was $6.30M, a 16.67% increase from fiscal 2022.
- Perrigo Company plc finance lease, right-of-use asset, amortization for fiscal 2022 was $5.40M, a 8.47% decline from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 3 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 6 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 9 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 12 month | Finance Lease, Right-of-Use Asset, Amortization 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-27 | $500.00K 10-Q · filed 2026-08-05 | $1.00M 10-Q · filed 2026-08-05 | $1.60M derived: sum of 3 quarters · filed 2026-08-05 | $2.20M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-28 | $500.00K 10-Q · filed 2026-05-06 | $1.10M derived: sum of 2 quarters · filed 2026-05-06 | $1.70M derived: sum of 3 quarters · filed 2026-05-06 | $2.30M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.20M derived: sum of 2 quarters · filed 2026-02-26 | $1.80M derived: sum of 3 quarters · filed 2026-08-05 | $2.30M 10-K · filed 2026-02-26 | ||||
| 2025-09-27 | $600.00K 10-Q · filed 2025-11-05 | $1.20M derived: sum of 2 quarters · filed 2026-08-05 | $1.70M 10-Q · filed 2025-11-05 | $2.30M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-28 | $600.00K 10-Q · filed 2026-08-05 | $1.20M 10-Q · filed 2026-08-05 | $1.70M derived: sum of 3 quarters · filed 2026-08-05 | $2.30M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-29 | $500.00K 10-Q · filed 2026-05-06 | $1.10M derived: sum of 2 quarters · filed 2026-05-06 | $1.70M derived: sum of 3 quarters · filed 2026-05-06 | $2.20M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.20M derived: sum of 2 quarters · filed 2026-02-26 | $1.70M derived: sum of 3 quarters · filed 2026-02-26 | $2.30M 10-K · filed 2026-02-26 | ||||
| 2024-09-28 | $600.00K 10-Q · filed 2025-11-05 | $1.10M derived: sum of 2 quarters · filed 2025-11-05 | $1.70M 10-Q · filed 2025-11-05 | $4.90M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-29 | $500.00K 10-Q · filed 2025-08-06 | $1.10M 10-Q · filed 2025-08-06 | $4.30M derived: sum of 3 quarters · filed 2026-02-26 | $5.20M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-30 | $600.00K 10-Q · filed 2025-05-07 | $3.80M derived: sum of 2 quarters · filed 2026-02-26 | $4.70M derived: sum of 3 quarters · filed 2026-02-26 | $5.80M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.10M derived: sum of 2 quarters · filed 2026-02-26 | $5.20M derived: sum of 3 quarters · filed 2026-02-26 | $6.30M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $900.00K 10-Q · filed 2024-11-06 | $2.00M derived: sum of 2 quarters · filed 2024-11-06 | $3.10M 10-Q · filed 2024-11-06 | $4.30M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-07-01 | $1.10M 10-Q · filed 2024-08-02 | $2.20M 10-Q · filed 2024-08-02 | $3.40M derived: sum of 3 quarters · filed 2025-02-28 | $4.70M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-04-01 | $1.10M 10-Q · filed 2024-05-07 | $2.30M derived: sum of 2 quarters · filed 2025-02-28 | $3.60M derived: sum of 3 quarters · filed 2025-02-28 | $5.00M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $2.50M derived: sum of 2 quarters · filed 2025-02-28 | $3.90M derived: sum of 3 quarters · filed 2025-02-28 | $5.40M 10-K · filed 2025-02-28 | ||||
| 2022-10-01 | $1.30M 10-Q · filed 2023-11-07 | $2.70M derived: sum of 2 quarters · filed 2023-11-07 | $4.20M 10-Q · filed 2023-11-07 | $5.70M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-07-02 | $1.40M 10-Q · filed 2023-08-08 | $2.90M 10-Q · filed 2023-08-08 | $4.40M derived: sum of 3 quarters · filed 2024-02-27 | $5.90M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-04-02 | $1.50M 10-Q · filed 2023-05-09 | $3.00M derived: sum of 2 quarters · filed 2024-02-27 | $4.50M derived: sum of 3 quarters · filed 2024-02-27 | $6.00M derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2021-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $3.00M derived: sum of 2 quarters · filed 2024-02-27 | $4.50M derived: sum of 3 quarters · filed 2024-02-27 | $5.90M 10-K · filed 2024-02-27 | ||||
| 2021-10-02 | $1.50M 10-Q · filed 2022-11-08 | $3.00M derived: sum of 2 quarters · filed 2022-11-08 | $4.40M 10-Q · filed 2022-11-08 | $5.70M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-07-03 | $1.50M 10-Q · filed 2022-08-09 | $3.00M 10-Q · filed 2022-08-09 | $4.20M derived: sum of 3 quarters · filed 2023-02-28 | $5.30M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-04-03 | $1.50M 10-Q · filed 2022-05-11 | $2.70M derived: sum of 2 quarters · filed 2023-02-28 | $3.80M derived: sum of 3 quarters · filed 2023-02-28 | $4.80M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $2.30M derived: sum of 2 quarters · filed 2023-02-28 | $3.30M derived: sum of 3 quarters · filed 2023-02-28 | $4.40M 10-K · filed 2023-02-28 | $4.80M 10-K · filed 2021-03-01 | |||
| 2020-09-26 | $1.10M 10-Q · filed 2021-11-12 | $1.20M 10-Q · filed 2020-11-05 | $2.10M derived: sum of 2 quarters · filed 2021-11-12 | $3.20M 10-Q · filed 2021-11-12 | $3.40M 10-Q · filed 2020-11-05 | $4.00M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-27 | $1.00M 10-Q · filed 2021-08-11 | $1.10M 10-Q · filed 2020-08-05 | $2.00M 10-Q · filed 2021-08-11 | $2.20M 10-Q · filed 2020-08-05 | $2.90M derived: sum of 3 quarters · filed 2021-08-11 | $3.80M derived: sum of 4 quarters · filed 2021-08-11 | ||
| 2020-03-28 | $1.00M 10-Q · filed 2021-05-12 | $1.10M 10-Q · filed 2020-05-05 | $1.90M derived: sum of 2 quarters · filed 2021-05-12 | $2.80M derived: sum of 3 quarters · filed 2021-05-12 | $3.50M derived: sum of 4 quarters · filed 2021-05-12 | |||
| 2019-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.80M derived: sum of 2 quarters · filed 2021-03-01 | $2.50M derived: sum of 3 quarters · filed 2021-03-01 | $3.20M 10-K · filed 2021-03-01 | ||||
| 2019-09-28 | $900.00K 10-Q · filed 2020-11-05 | $1.60M derived: sum of 2 quarters · filed 2020-11-05 | $2.30M 10-Q · filed 2020-11-05 | |||||
| 2019-06-29 | $700.00K 10-Q · filed 2020-08-05 | $1.30M 10-Q · filed 2020-08-05 | ||||||
| 2019-03-30 | $700.00K 10-Q · filed 2020-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |